China Pharma (NYSE:CPHI) Research Coverage Started at StockNews.com

Equities research analysts at StockNews.com began coverage on shares of China Pharma (NYSE:CPHI) in a note issued to investors on Saturday. The firm set a “hold” rating on the stock.

China Pharma Stock Performance

NYSE:CPHI opened at $0.32 on Friday. The company has a quick ratio of 0.33, a current ratio of 0.88 and a debt-to-equity ratio of 0.19. The stock has a fifty day simple moving average of $0.39 and a 200-day simple moving average of $0.48. China Pharma has a 52-week low of $0.30 and a 52-week high of $2.70.

About China Pharma

China Pharma Holdings, Inc develops, manufactures, and markets generic and branded pharmaceutical, and biochemical products primarily to hospitals and private retailers in the People's Republic of China. The company offers products in the form of dry powder injectables, liquid injectables, tablets, capsules, and cephalosporin oral solutions.